Pandemic darling $ARKK closing in yet again on a roundtrip & possible retest of its COVID-19 low. Traders - is the R/R good enough at these levels? Investors - do you believe in the fund that itself is very long term focused, yet has underperformed vs a majority of ETFs?

Personally not interested but I believe is a great case study.